These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias. Morgante F, Espay AJ, Gunraj C, Lang AE, Chen R. Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674 [Abstract] [Full Text] [Related]
4. Impaired activity of the supplementary motor area in akinetic patients with Parkinson's disease. Improvement by the dopamine agonist apomorphine. Rascol OJ, Sabatini U, Chollet F, Montastruc JL, Marc-Vergnes JP, Rascol A. Adv Neurol; 1993 Apr; 60():419-21. PubMed ID: 8420165 [No Abstract] [Full Text] [Related]
5. Apomorphine in patients with Parkinson's disease. Muguet D, Broussolle E, Chazot G. Biomed Pharmacother; 1995 Apr; 49(4):197-209. PubMed ID: 7669939 [Abstract] [Full Text] [Related]
6. Cortical inhibition in Parkinson's disease: new insights from early, untreated patients. Cantello R, Tarletti R, Varrasi C, Cecchin M, Monaco F. Neuroscience; 2007 Nov 30; 150(1):64-71. PubMed ID: 17964730 [Abstract] [Full Text] [Related]
7. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy]. Rouco I, Gómez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, Pérez Bas M, Hurtado P, Cruz Lachén M, Zarranz JJ. Neurologia; 2006 Apr 30; 21(3):119-23. PubMed ID: 16575624 [Abstract] [Full Text] [Related]
8. Neurophysiology of sensorimotor integration in Parkinson's disease. Rossini PM, Filippi MM, Vernieri F. Clin Neurosci; 1998 Apr 30; 5(2):121-30. PubMed ID: 10785838 [Abstract] [Full Text] [Related]
9. Changes in processing of proprioceptive information in Parkinson's disease and multiple system atrophy. Schrader C, Peschel T, Däuper J, Rollnik JD, Dengler R, Kossev AR. Clin Neurophysiol; 2008 May 30; 119(5):1139-46. PubMed ID: 18308627 [Abstract] [Full Text] [Related]
10. Reciprocal facilitation of motor evoked potentials immediately before voluntary movements in Parkinson's disease. Imai T, Yamamoto T, Ohkubo Y, Kashiwagi M, Chiba S, Matsumoto H. Electromyogr Clin Neurophysiol; 1999 Jun 30; 39(4):201-6. PubMed ID: 10394502 [Abstract] [Full Text] [Related]
12. Study of central motor functions using magnetic stimulation in Parkinson's disease. Diószeghy P, Hidasi E, Mechler F. Electromyogr Clin Neurophysiol; 1999 Mar 14; 39(2):101-5. PubMed ID: 10207679 [Abstract] [Full Text] [Related]
13. Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: implications for the pathophysiology of cortical function. Gilio F, Currà A, Inghilleri M, Lorenzano C, Manfredi M, Berardelli A. Mov Disord; 2002 May 14; 17(3):467-73. PubMed ID: 12112192 [Abstract] [Full Text] [Related]
14. Relief of akinesia by apomorphine and cerebral metabolic changes in Parkinson's disease. Broussolle E, Cinotti L, Pollak P, Landais P, Le Bars D, Galy G, Lavenne F, Khalfallah Y, Chazot G, Mauguière F. Mov Disord; 1993 Oct 14; 8(4):459-62. PubMed ID: 8232355 [Abstract] [Full Text] [Related]
15. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease. Lefaucheur JP, Drouot X, Von Raison F, Ménard-Lefaucheur I, Cesaro P, Nguyen JP. Clin Neurophysiol; 2004 Nov 14; 115(11):2530-41. PubMed ID: 15465443 [Abstract] [Full Text] [Related]
16. Excitability of the lower-limb area of the motor cortex in Parkinson's disease. Vacherot F, Attarian S, Eusebio A, Azulay JP. Neurophysiol Clin; 2010 Aug 14; 40(4):201-8. PubMed ID: 20674816 [Abstract] [Full Text] [Related]